RxDoctor Payments Data

Dawn Phelps, MD

Obstetrics · Harrison, ARNPI 1306048251

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $911 of the $1,080 with a category attached, or 84.3%. 22 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 26.2% of the total.

$1,080in general payments, 2019–2025

Across 49 payments — averaging $22.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$283
  • Therapeuticsmd, Inc.$121
  • Amgen$83
  • Astellas Pharma US Inc$83
  • GSK$74
  • Viiv Healthcare Company$56
  • plus $380 from 16 others

What the payments were for

  • Food & beverage$91184%
  • Education$16916%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few obstetrics providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$991
Medicare patients
32
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron11$5,068
Clobetasol Propionate58$4,725
Estradiol172$4,666
PremarinEstrogens, Conjugated11$2,292
EluryngEtonogestrel/Ethinyl Estradiol16$1,080
Norethindrone Acetate19$826
Medroxyprogesterone Acetate72$624
Oxybutynin Chloride ErOxybutynin Chloride52$589
ValacyclovirValacyclovir Hcl16$465
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$401
Nystatin18$240
Fluconazole18$237
Spironolactone15$134
Bupropion XlBupropion Hcl13$82

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$83$5,06811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few obstetrics providers in Arkansason file to place this against a meaningful peer group, so we don't.

Other obstetrics in Harrison

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →